Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
August, biomarker, clearance, document, electronic, improvement, issuer, key, longer, qualify, seasoned, startup
Removed:
adhigh, adjustment, Administration, alternative, authority, case, Christopher, Collier, combination, Comparison, complaint, concentrated, court, dated, David, dismissed, district, dosing, Dr, Drutz, Eastern, exchanged, Exchanging, expensed, facility, Food, Garg, governmental, hold, identifiable, IND, initiation, intellectual, Investigational, investor, jurisdiction, lack, leaving, License, motion, November, patient, personal, pharmaceutical, Plaintiff, preclinical, prejudice, prior, privately, recapitalization, referred, refiled, regulatory, rejected, remain, removed, reorganization, Representative, representing, reverse, single, sixty, split, Springfield, Stockholder, submission, support, Tang, unregistered, upfront, Vipin, wholly, world
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view